Raymond James Financial Inc. (RJF)
| Bid | 170.6 |
| Market Cap | 34.02B |
| Revenue (ttm) | 15.57B |
| Net Income (ttm) | 2.13B |
| EPS (ttm) | 10.2 |
| PE Ratio (ttm) | 16.73 |
| Forward PE | 14.26 |
| Analyst | Hold |
| Ask | 170.69 |
| Volume | 487,315 |
| Avg. Volume (20D) | 1,021,361 |
| Open | 170.33 |
| Previous Close | 171.08 |
| Day's Range | 169.36 - 171.45 |
| 52-Week Range | 116.90 - 174.32 |
| Beta | 1.06 |
About RJF
Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The Private Client Group segment offers investment services, portfolio management services, insurance and annuity products, and mutual funds; support to third-party product partners, including...
Financial Performance
In 2024, Raymond James Financial's revenue was $14.74B, an increase of 14.8% compared to the previous year's $12.84B. Earnings were $2.07B, an increase of 18.92%.
Financial StatementsAnalyst Forecast
According to 10 analyst ratings, the average rating for RJF stock is "Hold." The 12-month stock price forecast is $171, which is an increase of 0.21% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · https://thefly.com
Palvella Therapeutics initiated with an Outperform at Raymond JamesRaymond James initiated coverage of Palvella Therapeutics with an Outperform rating and $54 price target. The firm says the company is developing Qtorin rapamycin, a novel topical therapy designed to ...
1 month ago · seekingalpha.com
Raymond James: Rising Markets Offset Cash Headwinds (Rating Upgrade)Raymond James Financial's fundamentals remain strong, with higher AUM and resilient net interest income despite recent earnings noise from a one-time legal reserve. Client cash outflows and potential ...
